Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/36033
Title: | One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020–21) | Authors: | Meurisse, Marjan LAJOT, Adrien Dupont, Yves Lesenfants, Marie Klamer, Sofieke Rebolledo, Javiera Lernout, Tine Leroy, Mathias Capron, Arnaud Van Bussel, Johan Quoilin, Sophie Andre, Emmanuel Kehoe, Kaat WAUMANS, Luc Van Acker, Jos Vandenberg, Olivier Van den Wijngaert, Sigi Verdonck, Ann Cuypers, Lize Van Cauteren, Dieter |
Issue Date: | 2021 | Publisher: | BMC | Source: | ARCHIVES OF PUBLIC HEALTH, 79 (1) (Art N° 188) | Abstract: | Background With the spread of coronavirus disease 2019 (COVID-19), an existing national laboratory-based surveillance system was adapted to daily monitor the epidemiological situation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Belgium by following the number of confirmed SARS-CoV-2 infections, the number of performed tests and the positivity ratio. We present these main indicators of the surveillance over a one-year period as well as the impact of the performance of the laboratories, regarding speed of processing the samples and reporting results, for surveillance. Methods We describe the evolution of test capacity, testing strategy and the data collection methods during the first year of the epidemic in Belgium. Results Between the 1(st) of March 2020 and the 28(th) of February 2021, 9,487,470 tests and 773,078 COVID-19 laboratory confirmed cases were reported. Two epidemic waves occurred, with a peak in April and October 2020. The capacity and performance of the laboratories improved continuously during 2020 resulting in a high level performance. Since the end of November 2020 90 to 95% of the test results are reported at the latest the day after sampling was performed. Conclusions Thanks to the effort of all laboratories a performant exhaustive national laboratory-based surveillance system to monitor the epidemiological situation of SARS-CoV-2 was set up in Belgium in 2020. On top of expanding the number of laboratories performing diagnostics and significantly increasing the test capacity in Belgium, turnaround times between sampling and testing as well as reporting were optimized over the first year of this pandemic. | Notes: | Meurisse, M (corresponding author), Sciensano, Serv Epidemiol Infect Dis, Sci Directorate Epidemiol & Publ Hlth, J Wytsmanstr 14, B-1050 Brussels, Belgium. Marjan.Meurisse@sciensano.be |
Keywords: | COVID-19; SARS-CoV-2; Belgium; Laboratory-based surveillance | Document URI: | http://hdl.handle.net/1942/36033 | ISSN: | 0778-7367 | e-ISSN: | 2049-3258 | DOI: | 10.1186/s13690-021-00704-2 | ISI #: | WOS:000712566900001 | Rights: | © The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s13690-021-00704-2.pdf | Published version | 1.88 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.